Concurrent renal dysfunction with ischemic heart disease is an important determinant for cardiac and cerebrovascular mortality in patients on chronic digoxin therapy for atrial fibrillation

Concurrent renal dysfunction with ischemic heart disease is an important determinant for cardiac and cerebrovascular mortality in patients on chronic digoxin therapy for atrial fibrillation

Background : Major adverse cardiac and cerebrovascular events (MACCEs) are main concerns in patients with atrial fibrillation (AF); however, factors affecting MACCEs remain inconclusive in AF patients chronically treated with digoxin. We investigated the major clinical determinants for fatal MACCEs...

Full description

Bibliographic Details
Main Authors: Jong Ho Shin, Ki-Woon Kang, Jae Guk Kim, Soo Joo Lee
Format: Article
Language:English
Published: The Korean Society of Nephrology 2018-06-01
Series:Kidney Research and Clinical Practice
Subjects:
Atrial fibrillation
Chronic renal insufficiency
Digoxin
Ischemic heart disease
Online Access:https://doi.org/10.23876/j.krcp.2018.37.2.130

Internet

https://doi.org/10.23876/j.krcp.2018.37.2.130

Similar Items